Profil
David Kita is the founder and Chief Scientific Officer at Verseon Corp.
since 2002.
He is also the founder and Chief Scientific Officer at Verseon International Corp.
since 2002.
Prior to his founding positions, Dr. Kita worked as the Director-Software & Algorithm Development at Hyseq Pharmaceuticals, Inc. from 1996 to 1999.
He then served as the Director-Research & Development at Pulsent Corp.
from 1999 to 2002.
Dr. Kita holds a doctorate degree from the University of Wisconsin.
Postes actifs de David Kita
| Sociétés | Poste | Début |
|---|---|---|
| VERSEON CORP | Founder | 01/01/2002 |
| VERSEON INTERNATIONAL CORPORATION | Founder | 01/01/2002 |
Anciens postes connus de David Kita
| Sociétés | Poste | Fin |
|---|---|---|
| Pulsent Corp. | Chief Tech/Sci/R&D Officer | 01/05/2002 |
| Hyseq Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/1999 |
Formation de David Kita
| University of Wisconsin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Verseon Corp.
 Verseon Corp. Miscellaneous Commercial ServicesCommercial Services Verseon Corp. engages in the business of developing and designing pharmaceutical products. The firm also focuses on drug discovery technology to seed growing portfolio of programs targeting diverse disease areas which includes anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. The company was founded by Eniko Fodor, David Kita, and Adityo Prakash in 2002 and is headquartered in Fremont, CA. | Commercial Services |
| Hyseq Pharmaceuticals, Inc. | |
| Pulsent Corp. | |
| VERSEON INTERNATIONAL CORPORATION |
